1. Home
  2. IZEA vs BCTX Comparison

IZEA vs BCTX Comparison

Compare IZEA & BCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IZEA
  • BCTX
  • Stock Information
  • Founded
  • IZEA 2006
  • BCTX 2014
  • Country
  • IZEA United States
  • BCTX Canada
  • Employees
  • IZEA N/A
  • BCTX N/A
  • Industry
  • IZEA Advertising
  • BCTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • IZEA Consumer Discretionary
  • BCTX Health Care
  • Exchange
  • IZEA Nasdaq
  • BCTX Nasdaq
  • Market Cap
  • IZEA 29.1M
  • BCTX 23.5M
  • IPO Year
  • IZEA N/A
  • BCTX N/A
  • Fundamental
  • Price
  • IZEA $2.80
  • BCTX $2.11
  • Analyst Decision
  • IZEA
  • BCTX Strong Buy
  • Analyst Count
  • IZEA 0
  • BCTX 1
  • Target Price
  • IZEA N/A
  • BCTX $32.00
  • AVG Volume (30 Days)
  • IZEA 40.1K
  • BCTX 802.3K
  • Earning Date
  • IZEA 08-13-2025
  • BCTX 06-16-2025
  • Dividend Yield
  • IZEA N/A
  • BCTX N/A
  • EPS Growth
  • IZEA N/A
  • BCTX N/A
  • EPS
  • IZEA N/A
  • BCTX N/A
  • Revenue
  • IZEA $36,896,490.00
  • BCTX N/A
  • Revenue This Year
  • IZEA $22.24
  • BCTX N/A
  • Revenue Next Year
  • IZEA N/A
  • BCTX N/A
  • P/E Ratio
  • IZEA N/A
  • BCTX N/A
  • Revenue Growth
  • IZEA 7.17
  • BCTX N/A
  • 52 Week Low
  • IZEA $1.68
  • BCTX $2.05
  • 52 Week High
  • IZEA $3.15
  • BCTX $29.40
  • Technical
  • Relative Strength Index (RSI)
  • IZEA 44.91
  • BCTX 23.93
  • Support Level
  • IZEA $2.56
  • BCTX $2.85
  • Resistance Level
  • IZEA $2.71
  • BCTX $3.00
  • Average True Range (ATR)
  • IZEA 0.13
  • BCTX 0.18
  • MACD
  • IZEA -0.02
  • BCTX -0.05
  • Stochastic Oscillator
  • IZEA 20.06
  • BCTX 5.41

About IZEA IZEA Worldwide Inc.

IZEA Worldwide Inc offers solutions that range from creator agency services to creator technologies to a marketplace that connects marketers with creators. The Company provides value through managing custom content workflow, creator search and targeting, bidding, analytics, and payment processing. The company also enables creators to monetize their content, creativity, and influence through brands and marketers. The company compensates these creators for producing content, such as long and short-form text, videos, photos, status updates, and illustrations, for marketers or distributing such content on behalf of marketers through their websites, blogs, and social media channels.

About BCTX BriaCell Therapeutics Corp.

BriaCell Therapeutics Corp is a clinical-stage immuno-oncology company. The group is developing an entirely new class of targeted immunotherapies to transform cancer care. Its product candidate Bria-IMT, is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer (MBC is breast cancer that has spread to other tissues). Bria-IMT is a targeted cell-based immunotherapy. The company is engaged in developing a Bria-OTS platform of personalized off-the-shelf cell-based immunotherapies. It is being evaluated in a Phase 1/2 clinical study and the treatment is initially focused on patients with breast cancer with an extension to prostate cancer, and other cancers.

Share on Social Networks: